US FDA Approved Jemincare to Initiate Clinical Trial of Neutra... - 02 April 2021 17:10

SHANGHAI, Apr. 2, 2021 /Xinhua-AsiaNet/-- On March 31, 2021, Jemincare group announced that their anti-SARS-CoV-2 neutralizing antibody, JMB2002, independently developed by Jemincare Shanghai Research Center, was approved by FDA for clinical trial in the United States. Preclinical data...

  LimaCorporate Announces the Successful Completion of the First... - 01 April 2021 23:00

SAN DANIELE DEL FRIULI, Italy, April 1, 2021 /PRNewswire-AsiaNet/ -- LimaCorporate achieves an important landmark in the development of its digital platform designed to assist surgeons in delivering improved outcomes with an accessible and sustainable economic model, following the milestone-based acquisition of Tec...

  MGI COVID-19 Container Lab Put to Test, Safeguarding the World... - 01 April 2021 20:37

STOCKHOLM, April 1, 2021 /PRNewswire-AsiaNet/ -- The weeklong ISU World Figure Skating Championships (the Championships), an Olympic qualification event, were held in Stockholm, Sweden in late March. The world's top figure skaters from around the world had travelled to Sweden to compete for the ...

  Frontier Pharma and Baystone Group completes its acquisition o... - 01 April 2021 16:00

LONDON and BELGRADE, Serbia, April 1, 2021 /PRNewswire-AsiaNet/ -- - Zdravlje is a leading pharmaceutical manufacturer which supplies more than 35 countries around the world - The Company has a 65+ year track record in supplying high quality pharmaceutical products across oral solid and liquid forms - Zd...

  Alfasigma: It's Vein Week from 5th to 11th of April - 01 April 2021 09:18

BOLOGNA, Italy, April 1, 2021 /PRNewswire-AsiaNet/ -- - v-WIN Foundation and Alfasigma together to fight one of the leading causes of preventable death: venous thrombosis - Italy as the hub of an international public awareness project on venous and lymphatic health of the legs to be presented in ...

  Future Health: Innovative Health Around the World - 31 March 2021 22:21

LONDON, March 31, 2021 /PRNewswire-AsiaNet/ -- It started with the UK but the renowned organisers of Future Health Innovation have recently announced the launch of a full series of digital events - the Health Week Series. Concentrating on key markets around the world, there will be a Summer an...

  European Commission Approves mAbxience's Bevacizumab For The T... - 31 March 2021 12:30

MADRID, March 31, 2021 /PRNewswire-AsiaNet/ -- - mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceuticals, is expanding patient access to biological treatments throughout Europe. The Europ...

  Menarini Silicon Biosystems launches CELLSEARCH(R) Circulating... - 31 March 2021 12:00

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., March 31, 2021 /PRNewswire-AsiaNet/ -- -- The new test, available as a Lab Service throughout Europe and US, leverages the Gold Standard CELLSEARCH platform to enumerate Circulating Multiple Myeloma Cells from blood and offers real-time standardized monitoring of multiple myeloma in cl...

  Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement ... - 31 March 2021 04:42

WETTEREN, Belgium, March 31, 2021 /PRNewswire-AsiaNet/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a manufacturing agreement expansion with AstraZeneca to include drug product manufact...

  GemVax's highly promising Phase II Alzheimer's disease clinica... - 30 March 2021 22:59

SEOUL, South Korea, March 30, 2021 /PRNewswire-AsiaNet/ -- GemVax & KAEL Co., Ltd. (Korea: 082270) ("GemVax") has announced that a paper on GV1001, a novel Alzheimer's treatment based on telomerase modification, was published on March 26th in the SCI-grade international journal 'Alzheimer's Research & The...